Policy Recommendations for Strengthening the Accelerated Approval Program for Oncology Drugs
Memo: Delivered to the U.S. Food and Drug Administration (FDA)
Policy
Health Care Market Consolidation and Private Equity Funds
Comment: Health Care Market Consolidation and Private Equity FundsSubmitted to U.S. Department of Justice, Department of Health and Human Services, and Federal Trade Commission
Print:
On May 6th, 2024, University of Pennsylvania Leonard Davis Institute of Health Economics (LDI) Executive Director Rachel M. Werner, MD, PhD submitted a public comment in response to a Request for Information (RFI) on consolidation in health care and the effects of transactions conducted by private equity funds or other alternative asset managers, health systems, or private payers. Werner provides an overview of the evidence on the impacts of health care consolidation of hospitals, with a specific focus on health equity, including low-income Medicaid beneficiaries.
More on Policy at LDI
Estimated Overdose Deaths Due to the One Big Beautiful Bill Act
Research Memo: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Health Impacts of SNAP Provisions in the One Big Beautiful Bill Act
Research Memo: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Impact of House Budget Reconciliation Bill on Insurance Coverage
Comment: Delivered to the Senate Committee on Health, Education, Labor, and Pensions
Projected Mortality Impacts of the Budget Reconciliation Bill
Research Memo: Response to Request for Technical Assistance
Loss of Subsidized Drug Coverage and Mortality Following Medicaid Disenrollment: Translating our Findings and Implications for Medicaid Policy
Research Memo: Supplement to Response to Request for Technical Assistance